168
Views
31
CrossRef citations to date
0
Altmetric
Original Article

Ultrastructural Descriptions of Heterotypic Aggregation between Eosinophils and Tumor Cells in Human Gastric Carcinomas

, MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD & , MD show all
Pages 145-149 | Received 19 Mar 2011, Accepted 28 Mar 2011, Published online: 09 Jun 2011

REFERENCES

  • Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002;3:991–998
  • Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol. 2004;22:329–360.
  • De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol. 2003;200:429–447.
  • Elishmereni M, Alenius HT, Bradding P, et al. Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro. Allergy. 2011;66:376–385
  • Bachelet I, Levi-Schaffer F, Mekori YA. Mast cells: not only in allergy. Immunol Allergy Clin North Am. 2006;26:407–425.
  • Samoszuk M. Eosinophils and human cancer. Histol Histopathol. 1997;12:807–812
  • Caruso RA, Bersiga A, Rigoli L, Inferrera C. Eosinophil-tumor cell interaction in advanced gastric carcinoma: an electron microscopic approach. Anticancer Res. 2002;22:3833–3836.
  • Caruso RA, Giuffrè G, Inferrera C. Minute and small early gastric carcinoma with special reference to eosinophil infiltration. Histol Histopathol. 1993;8:155–166.
  • Cuschieri A, Talbot IC, Weeden S; MRC Upper GI Cancer Working Party. Influence of pathological tumour variables on long-term survival in resectable gastric cancer. Br J Cancer. 2002;86:674–679.
  • Teixeira MM, Rossi AG, Hellewell PG. Adhesion mechanisms involved in C5a-induced eosinophil homotypic aggregation. J Leukoc Biol. 1996;59:389–396.
  • Koenderman L, Kuijpers TW, Blom M, Tool AT, Roos D, Verhoeven AJ. Characteristics of CR3-mediated aggregation in human eosinophils: effect of priming by platelet-activating factor. J Allergy Clin Immunol. 1991;87:947–954.
  • Melo RCN, Spencer L, Perez SAC, et al. Vesicle-mediated secretion of human eosinophil granule-derived major basic protein (MBP). Lab Invest. 2009; 89: 769–781
  • Lee JJ, Jacobsen EA, McGarry MP, Schleimer RP, Lee NA. Eosinophils in health and disease: the LIAR hypothesis. Clin Exp Allergy. 2010;40:563–575
  • Lotfi R, Herzog GI, DeMarco RA, et al. Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells. J Immunol. 2009;183:5023–5031.
  • Lotfi R, Lee JJ, Lotze MT. Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors. J Immunother. 2007;30:16–28
  • Cormier SA, Taranova AG, Bedient C, et al. Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol. 2006;79:1131–1139.
  • Bosco M, Giovarelli M, Forni M, et al. Low doses of IL-4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory. J Immunol. 1990;145:3136–143.
  • Modesti A, Masuelli L, Modica A, et al. Ultrastructural evidence of the mechanisms responsible for interleukin-4-activated rejection of a spontaneous murine adenocarcinoma. Int J Cancer. 1993;53:988–993.
  • Anderson RG. The caveolae membrane system. Annu Rev Biochem. 1998;67:199–225.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.